White Paper
Clinical Trials In Diabetes: Challenges In Patient Recruitment
Click Here To Download:
•Article: Clinical Trials In Diabetes: Challenges In Patient Recruitment
Written and compiled by Debby Holmes, Senior Director, Clinical Operations and Bettina Peterson, Senior Clinical Manager, ICON Clinical Research
Diabetes is a serious, costly, and increasingly common disease, which constitutes a huge health problem in both developed and developing countries.
Diabetes is one of the largest therapeutic areas in terms of global pharmaceutical sales. During the last 10 years, the market has grown by a compound average growth rate of nearly 20%. Due to the increasing prevalence of the disease, the market for antidiabetic drugs is expected to grow dramatically over the next 5 years to more than $22 billion.
Because of the large number of patients and trial sites needed for diabetes trials, they can be complicated to set up and run. In this competitive environment, there are several challenges that must be overcome in order to conduct a successful trial on time and on budget.
Click Here To Download:•Article: Clinical Trials In Diabetes: Challenges In Patient Recruitment
